CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-06 | Brunn Carsten President and CEO | Sale | −23,766 | $6.82 | $162K | 323,530 |
| 2026-01-02 | Brunn Carsten President and CEO | Grant or award | +143,200 | 347,296 | ||
| 2026-01-02 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +415,700 | 415,700 | ||
| 2025-01-06 | Brunn Carsten President and CEO | Sale | −8,708 | $16.83 | $147K | 204,096 |
| 2025-01-03 | Brunn Carsten President and CEO | Sale | −8,563 | $16.72 | $143K | 212,804 |
| 2025-01-02 | Brunn Carsten President and CEO | Grant or award | +57,500 | 221,367 | ||
| 2025-01-02 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +169,100 | 169,100 | ||
| 2024-01-02 | Brunn Carsten President and CEO | Grant or award | +4,654,100 | 4,916,056 | ||
| 2024-01-02 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +5,971,000 | 5,971,000 | ||
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company | −55,000 | $2.06 | $113K | 728,081 |
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company | −13,600 | $2.06 | $28K | 714,481 |
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company | −169,725 | $2.06 | $350K | 544,756 |
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company | −282,800 | $2.06 | $583K | 261,956 |
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company · Employee Stock Option (right to buy) | −1,000,000 | 0 | ||
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company · Employee Stock Option (right to buy) | −330,000 | 0 | ||
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company · Employee Stock Option (right to buy) | −400,000 | $0.31 | $124K | 0 |
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company · Employee Stock Option (right to buy) | −600,000 | 0 | ||
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company · Employee Stock Option (right to buy) | −75,000 | 0 | ||
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company · Employee Stock Option (right to buy) | −670,000 | 0 | ||
| 2023-11-13 | Brunn Carsten President and CEO | Returned to the company · Employee Stock Option (right to buy) | −163,000 | 0 |
Page 1 of 4 · 62 trades